Bentley Pharmaceuticals Announces Product Approvals in Europe
EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that its European subsidiaries have received approvals to market their omeprazole capsule products, through their licensees, in various territories in Europe.